Abstract
We studied 36 patients, allocated randomly to receive meloxicam 15 mg rectally (n = 18) or placebo suppository (n = 18) before total abdominal hysterectomy in a double-blind study. Visual analogue scores for pain at rest (P < 0.005), on movement (P < 0.05) and on coughing (P < 0.05) were significantly decreased in the meloxicam group during the first 24 h after surgery. Mean 24-h PCA morphine requirements were 33.2 (SD 16.9) mg and 38.2 (20.8) mg in the meloxicam and placebo groups, respectively (ns). There was no difference in the incidence of nausea, vomiting or sedation between groups.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Aged
-
Analgesia, Patient-Controlled
-
Analgesics, Non-Narcotic / therapeutic use*
-
Analgesics, Opioid / administration & dosage
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Cyclooxygenase Inhibitors / therapeutic use*
-
Double-Blind Method
-
Drug Administration Schedule
-
Female
-
Humans
-
Hysterectomy*
-
Meloxicam
-
Middle Aged
-
Morphine / administration & dosage
-
Pain Measurement
-
Pain, Postoperative / prevention & control*
-
Thiazines / therapeutic use*
-
Thiazoles / therapeutic use*
Substances
-
Analgesics, Non-Narcotic
-
Analgesics, Opioid
-
Anti-Inflammatory Agents, Non-Steroidal
-
Cyclooxygenase Inhibitors
-
Thiazines
-
Thiazoles
-
Morphine
-
Meloxicam